Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer
Background There is limited information on indocyanine green (ICG) fluorescence and blue dye for detecting sentinel lymph node (SLN) in early breast cancer. A retrospective study was conducted to assess the feasibility of an SLN biopsy using the combination of ICG fluorescence and the blue dye metho...
Gespeichert in:
| Veröffentlicht in: | Breast cancer (Tokyo, Japan) Japan), 2016-03, Vol.23 (2), p.295-300 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 300 |
|---|---|
| container_issue | 2 |
| container_start_page | 295 |
| container_title | Breast cancer (Tokyo, Japan) |
| container_volume | 23 |
| creator | Inoue, Tomoo Nishi, Toshio Nakano, Yoshiaki Nishimae, Ayaka Sawai, Yuka Yamasaki, Masaru Inaji, Hideo |
| description | Background
There is limited information on indocyanine green (ICG) fluorescence and blue dye for detecting sentinel lymph node (SLN) in early breast cancer. A retrospective study was conducted to assess the feasibility of an SLN biopsy using the combination of ICG fluorescence and the blue dye method.
Methods
Seven hundred and fourteen patients with clinically node-negative breast cancer were included in this study. They underwent SLN biopsy using a combination of ICG fluorescence and the blue dye method from March 2007 to February 2014. The ICG (a fluorescence-emitting source) and patent blue (the blue dye) were injected into the patients’ subareolar region. The removed lymph nodes that had ICG fluorescence and/or blue dye uptake were defined as SLNs. The results of the SLN biopsies and follow-up results of patients who underwent SLN biopsy alone were investigated.
Results
In 711 out of 714 patients, SLNs were identified by a combination of ICG fluorescence and the blue dye method (detection rate, 99.6 %). The average number of SLNs was 2.4 (range 1–7), and the average number of resected swollen para-SLNs was 0.4 (range 0–5). Ninety-nine patients with an SLN and/or para-SLN involvement during the intraoperative pathological diagnosis underwent axillary lymph node resection (ALND). In addition, two of three patients whose SLN was not identified also underwent ALND. In 46 of 101 patients with an ALND, non-SLN involvement was not found. Follow-up results were analyzed in 464 patients with invasive carcinoma excluding those with ductal carcinoma in situ (
n
= 148) and those who underwent ALND (
n
= 101). During the follow-up period (range 4.4–87.7 months; median, 38 months), two patients (0.4 %) developed axillary lymph node recurrence. They were successfully salvaged, and to date, no further locoregional recurrence has been observed.
Conclusions
A high rate of SLN detection and low rate of axillary lymph node recurrence were confirmed by an SLN biopsy using a combination of ICG fluorescence and the blue dye method. Therefore, it is suggested that this method may replace the combination of dye and radioisotope methods. |
| doi_str_mv | 10.1007/s12282-014-0573-8 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1770217138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712277122</galeid><sourcerecordid>A712277122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-e07ae81586961fddbb3080ab08aa8a18e8b4644dc3d81954a32f630eb36414353</originalsourceid><addsrcrecordid>eNp9kU2L3SAUhkNp6Xy0P6CbInTTTaYaTfQuL0O_YKCbdi1Gj_c6JJoeE2j-1PzGGjItLZQiqOjzHg8-VfWK0RtGqXyXWdOopqZM1LSVvFZPqkumFK1Fw_nTsueC1p3q1EV1lfM9pYJL2j2vLpqWC3Xg8rJ6OP4Iw2BwJcM6TmcSkwOCYBdEiBaI8TMgyRDnEGH4E-pDmvJKJkCfcARHlhziiRhi09iHaOaQIkmehOiSXU0seXJCgEj8sCSEbPcHoiPzuZQbFiBuBTLCfE6uxAgYHFbSI5g8E2sKjS-qZ94MGV4-rtfVtw_vv95-qu--fPx8e7yrbUvbuQYqDSjWqu7QMe9c33OqqOmpMkYZpkD1ohPCWe4UO7TC8MZ3nELPO8EEb_l19XavO2H6vkCe9RhKw-WnIqQlayYlbZhkXBX0zY6ezAA6RJ9mNHbD9VEWQXKbCnXzD6oMB2OwKYIP5fyvANsDFlPOCF5PGMYiSjOqN_t6t6-Lfb3Z11srrx-7Xvpi5Hfil-4CNDuQy1U8Aer7tGAsP_mfqj8Bg6m8XQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770217138</pqid></control><display><type>article</type><title>Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Inoue, Tomoo ; Nishi, Toshio ; Nakano, Yoshiaki ; Nishimae, Ayaka ; Sawai, Yuka ; Yamasaki, Masaru ; Inaji, Hideo</creator><creatorcontrib>Inoue, Tomoo ; Nishi, Toshio ; Nakano, Yoshiaki ; Nishimae, Ayaka ; Sawai, Yuka ; Yamasaki, Masaru ; Inaji, Hideo</creatorcontrib><description>Background
There is limited information on indocyanine green (ICG) fluorescence and blue dye for detecting sentinel lymph node (SLN) in early breast cancer. A retrospective study was conducted to assess the feasibility of an SLN biopsy using the combination of ICG fluorescence and the blue dye method.
Methods
Seven hundred and fourteen patients with clinically node-negative breast cancer were included in this study. They underwent SLN biopsy using a combination of ICG fluorescence and the blue dye method from March 2007 to February 2014. The ICG (a fluorescence-emitting source) and patent blue (the blue dye) were injected into the patients’ subareolar region. The removed lymph nodes that had ICG fluorescence and/or blue dye uptake were defined as SLNs. The results of the SLN biopsies and follow-up results of patients who underwent SLN biopsy alone were investigated.
Results
In 711 out of 714 patients, SLNs were identified by a combination of ICG fluorescence and the blue dye method (detection rate, 99.6 %). The average number of SLNs was 2.4 (range 1–7), and the average number of resected swollen para-SLNs was 0.4 (range 0–5). Ninety-nine patients with an SLN and/or para-SLN involvement during the intraoperative pathological diagnosis underwent axillary lymph node resection (ALND). In addition, two of three patients whose SLN was not identified also underwent ALND. In 46 of 101 patients with an ALND, non-SLN involvement was not found. Follow-up results were analyzed in 464 patients with invasive carcinoma excluding those with ductal carcinoma in situ (
n
= 148) and those who underwent ALND (
n
= 101). During the follow-up period (range 4.4–87.7 months; median, 38 months), two patients (0.4 %) developed axillary lymph node recurrence. They were successfully salvaged, and to date, no further locoregional recurrence has been observed.
Conclusions
A high rate of SLN detection and low rate of axillary lymph node recurrence were confirmed by an SLN biopsy using a combination of ICG fluorescence and the blue dye method. Therefore, it is suggested that this method may replace the combination of dye and radioisotope methods.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/s12282-014-0573-8</identifier><identifier>PMID: 25348937</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Analysis ; Axilla ; Biomarkers, Tumor - metabolism ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Cancer Research ; Carcinoma, Ductal ; Carcinoma, Ductal, Breast - metabolism ; Carcinoma, Ductal, Breast - pathology ; Carcinoma, Ductal, Breast - surgery ; Carcinoma, Lobular - metabolism ; Carcinoma, Lobular - pathology ; Carcinoma, Lobular - surgery ; Coloring Agents ; Female ; Fluorescence ; Follow-Up Studies ; Humans ; Image-Guided Biopsy - methods ; Immunoenzyme Techniques ; Indocyanine Green ; Lymph Nodes - metabolism ; Lymph Nodes - pathology ; Lymph Nodes - surgery ; Medicine ; Medicine & Public Health ; Methods ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - metabolism ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Neoplasm Staging ; Oncology ; Original Article ; Prognosis ; Receptor, ErbB-2 - metabolism ; Receptors, Estrogen - metabolism ; Receptors, Progesterone - metabolism ; Retrospective Studies ; Rosaniline Dyes ; Sentinel Lymph Node Biopsy ; Surgery ; Surgical Oncology</subject><ispartof>Breast cancer (Tokyo, Japan), 2016-03, Vol.23 (2), p.295-300</ispartof><rights>The Japanese Breast Cancer Society 2014</rights><rights>COPYRIGHT 2016 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-e07ae81586961fddbb3080ab08aa8a18e8b4644dc3d81954a32f630eb36414353</citedby><cites>FETCH-LOGICAL-c505t-e07ae81586961fddbb3080ab08aa8a18e8b4644dc3d81954a32f630eb36414353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12282-014-0573-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12282-014-0573-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25348937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inoue, Tomoo</creatorcontrib><creatorcontrib>Nishi, Toshio</creatorcontrib><creatorcontrib>Nakano, Yoshiaki</creatorcontrib><creatorcontrib>Nishimae, Ayaka</creatorcontrib><creatorcontrib>Sawai, Yuka</creatorcontrib><creatorcontrib>Yamasaki, Masaru</creatorcontrib><creatorcontrib>Inaji, Hideo</creatorcontrib><title>Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><addtitle>Breast Cancer</addtitle><description>Background
There is limited information on indocyanine green (ICG) fluorescence and blue dye for detecting sentinel lymph node (SLN) in early breast cancer. A retrospective study was conducted to assess the feasibility of an SLN biopsy using the combination of ICG fluorescence and the blue dye method.
Methods
Seven hundred and fourteen patients with clinically node-negative breast cancer were included in this study. They underwent SLN biopsy using a combination of ICG fluorescence and the blue dye method from March 2007 to February 2014. The ICG (a fluorescence-emitting source) and patent blue (the blue dye) were injected into the patients’ subareolar region. The removed lymph nodes that had ICG fluorescence and/or blue dye uptake were defined as SLNs. The results of the SLN biopsies and follow-up results of patients who underwent SLN biopsy alone were investigated.
Results
In 711 out of 714 patients, SLNs were identified by a combination of ICG fluorescence and the blue dye method (detection rate, 99.6 %). The average number of SLNs was 2.4 (range 1–7), and the average number of resected swollen para-SLNs was 0.4 (range 0–5). Ninety-nine patients with an SLN and/or para-SLN involvement during the intraoperative pathological diagnosis underwent axillary lymph node resection (ALND). In addition, two of three patients whose SLN was not identified also underwent ALND. In 46 of 101 patients with an ALND, non-SLN involvement was not found. Follow-up results were analyzed in 464 patients with invasive carcinoma excluding those with ductal carcinoma in situ (
n
= 148) and those who underwent ALND (
n
= 101). During the follow-up period (range 4.4–87.7 months; median, 38 months), two patients (0.4 %) developed axillary lymph node recurrence. They were successfully salvaged, and to date, no further locoregional recurrence has been observed.
Conclusions
A high rate of SLN detection and low rate of axillary lymph node recurrence were confirmed by an SLN biopsy using a combination of ICG fluorescence and the blue dye method. Therefore, it is suggested that this method may replace the combination of dye and radioisotope methods.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Axilla</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Cancer Research</subject><subject>Carcinoma, Ductal</subject><subject>Carcinoma, Ductal, Breast - metabolism</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Carcinoma, Ductal, Breast - surgery</subject><subject>Carcinoma, Lobular - metabolism</subject><subject>Carcinoma, Lobular - pathology</subject><subject>Carcinoma, Lobular - surgery</subject><subject>Coloring Agents</subject><subject>Female</subject><subject>Fluorescence</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Image-Guided Biopsy - methods</subject><subject>Immunoenzyme Techniques</subject><subject>Indocyanine Green</subject><subject>Lymph Nodes - metabolism</subject><subject>Lymph Nodes - pathology</subject><subject>Lymph Nodes - surgery</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm Staging</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Prognosis</subject><subject>Receptor, ErbB-2 - metabolism</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Receptors, Progesterone - metabolism</subject><subject>Retrospective Studies</subject><subject>Rosaniline Dyes</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2L3SAUhkNp6Xy0P6CbInTTTaYaTfQuL0O_YKCbdi1Gj_c6JJoeE2j-1PzGGjItLZQiqOjzHg8-VfWK0RtGqXyXWdOopqZM1LSVvFZPqkumFK1Fw_nTsueC1p3q1EV1lfM9pYJL2j2vLpqWC3Xg8rJ6OP4Iw2BwJcM6TmcSkwOCYBdEiBaI8TMgyRDnEGH4E-pDmvJKJkCfcARHlhziiRhi09iHaOaQIkmehOiSXU0seXJCgEj8sCSEbPcHoiPzuZQbFiBuBTLCfE6uxAgYHFbSI5g8E2sKjS-qZ94MGV4-rtfVtw_vv95-qu--fPx8e7yrbUvbuQYqDSjWqu7QMe9c33OqqOmpMkYZpkD1ohPCWe4UO7TC8MZ3nELPO8EEb_l19XavO2H6vkCe9RhKw-WnIqQlayYlbZhkXBX0zY6ezAA6RJ9mNHbD9VEWQXKbCnXzD6oMB2OwKYIP5fyvANsDFlPOCF5PGMYiSjOqN_t6t6-Lfb3Z11srrx-7Xvpi5Hfil-4CNDuQy1U8Aer7tGAsP_mfqj8Bg6m8XQ</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Inoue, Tomoo</creator><creator>Nishi, Toshio</creator><creator>Nakano, Yoshiaki</creator><creator>Nishimae, Ayaka</creator><creator>Sawai, Yuka</creator><creator>Yamasaki, Masaru</creator><creator>Inaji, Hideo</creator><general>Springer Japan</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160301</creationdate><title>Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer</title><author>Inoue, Tomoo ; Nishi, Toshio ; Nakano, Yoshiaki ; Nishimae, Ayaka ; Sawai, Yuka ; Yamasaki, Masaru ; Inaji, Hideo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-e07ae81586961fddbb3080ab08aa8a18e8b4644dc3d81954a32f630eb36414353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Axilla</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Cancer Research</topic><topic>Carcinoma, Ductal</topic><topic>Carcinoma, Ductal, Breast - metabolism</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Carcinoma, Ductal, Breast - surgery</topic><topic>Carcinoma, Lobular - metabolism</topic><topic>Carcinoma, Lobular - pathology</topic><topic>Carcinoma, Lobular - surgery</topic><topic>Coloring Agents</topic><topic>Female</topic><topic>Fluorescence</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Image-Guided Biopsy - methods</topic><topic>Immunoenzyme Techniques</topic><topic>Indocyanine Green</topic><topic>Lymph Nodes - metabolism</topic><topic>Lymph Nodes - pathology</topic><topic>Lymph Nodes - surgery</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm Staging</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Prognosis</topic><topic>Receptor, ErbB-2 - metabolism</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Receptors, Progesterone - metabolism</topic><topic>Retrospective Studies</topic><topic>Rosaniline Dyes</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inoue, Tomoo</creatorcontrib><creatorcontrib>Nishi, Toshio</creatorcontrib><creatorcontrib>Nakano, Yoshiaki</creatorcontrib><creatorcontrib>Nishimae, Ayaka</creatorcontrib><creatorcontrib>Sawai, Yuka</creatorcontrib><creatorcontrib>Yamasaki, Masaru</creatorcontrib><creatorcontrib>Inaji, Hideo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inoue, Tomoo</au><au>Nishi, Toshio</au><au>Nakano, Yoshiaki</au><au>Nishimae, Ayaka</au><au>Sawai, Yuka</au><au>Yamasaki, Masaru</au><au>Inaji, Hideo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><stitle>Breast Cancer</stitle><addtitle>Breast Cancer</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>23</volume><issue>2</issue><spage>295</spage><epage>300</epage><pages>295-300</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Background
There is limited information on indocyanine green (ICG) fluorescence and blue dye for detecting sentinel lymph node (SLN) in early breast cancer. A retrospective study was conducted to assess the feasibility of an SLN biopsy using the combination of ICG fluorescence and the blue dye method.
Methods
Seven hundred and fourteen patients with clinically node-negative breast cancer were included in this study. They underwent SLN biopsy using a combination of ICG fluorescence and the blue dye method from March 2007 to February 2014. The ICG (a fluorescence-emitting source) and patent blue (the blue dye) were injected into the patients’ subareolar region. The removed lymph nodes that had ICG fluorescence and/or blue dye uptake were defined as SLNs. The results of the SLN biopsies and follow-up results of patients who underwent SLN biopsy alone were investigated.
Results
In 711 out of 714 patients, SLNs were identified by a combination of ICG fluorescence and the blue dye method (detection rate, 99.6 %). The average number of SLNs was 2.4 (range 1–7), and the average number of resected swollen para-SLNs was 0.4 (range 0–5). Ninety-nine patients with an SLN and/or para-SLN involvement during the intraoperative pathological diagnosis underwent axillary lymph node resection (ALND). In addition, two of three patients whose SLN was not identified also underwent ALND. In 46 of 101 patients with an ALND, non-SLN involvement was not found. Follow-up results were analyzed in 464 patients with invasive carcinoma excluding those with ductal carcinoma in situ (
n
= 148) and those who underwent ALND (
n
= 101). During the follow-up period (range 4.4–87.7 months; median, 38 months), two patients (0.4 %) developed axillary lymph node recurrence. They were successfully salvaged, and to date, no further locoregional recurrence has been observed.
Conclusions
A high rate of SLN detection and low rate of axillary lymph node recurrence were confirmed by an SLN biopsy using a combination of ICG fluorescence and the blue dye method. Therefore, it is suggested that this method may replace the combination of dye and radioisotope methods.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>25348937</pmid><doi>10.1007/s12282-014-0573-8</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1340-6868 |
| ispartof | Breast cancer (Tokyo, Japan), 2016-03, Vol.23 (2), p.295-300 |
| issn | 1340-6868 1880-4233 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1770217138 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adult Aged Aged, 80 and over Analysis Axilla Biomarkers, Tumor - metabolism Breast Neoplasms - metabolism Breast Neoplasms - pathology Breast Neoplasms - surgery Cancer Research Carcinoma, Ductal Carcinoma, Ductal, Breast - metabolism Carcinoma, Ductal, Breast - pathology Carcinoma, Ductal, Breast - surgery Carcinoma, Lobular - metabolism Carcinoma, Lobular - pathology Carcinoma, Lobular - surgery Coloring Agents Female Fluorescence Follow-Up Studies Humans Image-Guided Biopsy - methods Immunoenzyme Techniques Indocyanine Green Lymph Nodes - metabolism Lymph Nodes - pathology Lymph Nodes - surgery Medicine Medicine & Public Health Methods Middle Aged Neoplasm Grading Neoplasm Invasiveness Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Neoplasm Staging Oncology Original Article Prognosis Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Retrospective Studies Rosaniline Dyes Sentinel Lymph Node Biopsy Surgery Surgical Oncology |
| title | Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A44%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Axillary%20lymph%20node%20recurrence%20after%20sentinel%20lymph%20node%20biopsy%20performed%20using%20a%20combination%20of%20indocyanine%20green%20fluorescence%20and%20the%20blue%20dye%20method%20in%20early%20breast%20cancer&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Inoue,%20Tomoo&rft.date=2016-03-01&rft.volume=23&rft.issue=2&rft.spage=295&rft.epage=300&rft.pages=295-300&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/s12282-014-0573-8&rft_dat=%3Cgale_proqu%3EA712277122%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770217138&rft_id=info:pmid/25348937&rft_galeid=A712277122&rfr_iscdi=true |